FDA NEWS

Novartis' bone-building drug gets new FDA approval - Forbes
Drug developer Novartis AG said Thursday the Food and Drug Administration approved the bone-building drug Reclast as a treatment to prevent additional fractures following a hip fracture. The once-yearly drug is already approved in the U.S. and Europe
Source: www.forbes.com

UPDATE: FDA To Restrict Wyeth Heartworm Drug Distribution - CNN Money
WASHINGTON -(Dow Jones)- The U.S. Food and Drug Administration on Thursday said it will allow a limited return to the market of Wyeth's (WYE) controversial anti-heartworm drug for dogs. Wyeth's unit, Fort Dodge Animal Health, voluntarily pulled the
Source: money.cnn.com

UCB granted pediatric exclusivity for epilepsy drug Keppra by U.S. FDA - Forbes
BRUSSELS (Thomson Financial) - Belgian pharmaceutical company UCB announced Friday that the U.S. Food and Drug Administration (FDA) has granted it pediatric exclusivity for the epilepsy treatment Keppra. The decision was based on pediatric data
Source: www.forbes.com

Group petitions FDA to ban some food colorings - Los Angeles Times
WASHINGTON -- A consumer advocacy group called on the Food and Drug Administration Tuesday to ban the use of eight artificial colorings in food because the additives may cause hyperactivity and behavior problems in some children. Controlled studies
Source: www.latimes.com

Fidelity's top lawyer resigns to be full-time law teacher - Boston Globe
FDA adds cancer warning to J&J foot ulcer medicine The Food and Drug Administration warned patients that using large amounts of a Johnson & Johnson foot ulcer medication could heighten their risk of dying from cancer. The FDA added its most serious
Source: www.boston.com